Acetanilide and bromoacetyl-lysine derivatives as activators for human histone deacetylase 8.
In the current study, seven compounds (i.e. 1-7) were found to be novel activators for the Nε-acetyl-lysine deacetylation reaction catalyzed by human histone deacetylase 8 (HDAC8). When assessed with the commercially available HDAC8 peptide substrate Fluor-de-Lys®-HDAC8 that harbors the unnatural 7-amino-4-methylcoumarin (AMC) residue immediately C-terminal to the Nε-acetyl-lysine residue to be deacetylated, our compounds exhibited comparable activation potency to that of TM-2-51, the strongest HDAC8 activator reported in the current literature. However, when assessed with an AMC-less peptide substrate derived from the native HDAC8 non-histone substrate protein Zinc finger protein ZNF318, while our compounds were all found to be able to activate HDAC8 deacetylation reaction, TM-2-51 was found not to be able to. Our compounds also seemed to be largely selective for HDAC8 over other classical HDACs. Moreover, treatment with the strongest activator among our compounds (i.e. 7) was found to decrease the KM of the above AMC-less HDAC8 substrate, while nearly maintaining the kcat of the HDAC8-catalyzed deacetylation on this substrate.
['Mukhtar|Yusif M|YM|', 'Huang|Yajun|Y|', 'Liu|Jiajia|J|', 'Chen|Di|D|', 'Zheng|Weiping|W|']
D000083:Acetanilides D000085:Acetates D020536:Enzyme Activators D006655:Histone Deacetylases D006801:Humans D008239:Lysine D012097:Repressor Proteins
Activator HDAC8 Classical HDAC K(M) depression